Ryman Healthcare Limited (RHCGF) Stock
Ryman Healthcare Limited specializes in the development, ownership, and operation of integrated senior living communities and aged care facilities, catering to elderly residents across New Zealand and Australia. Within its villages, the company offers a diverse array of residential choices, including independent living options such as townhouses and apartments, alongside serviced apartments.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Ryman Healthcare Limited
Ryman Healthcare Limited specializes in the development, ownership, and operation of integrated senior living communities and aged care facilities, catering to elderly residents across New Zealand and Australia. Within its villages, the company offers a diverse array of residential choices, including independent living options such as townhouses and apartments, alongside serviced apartments. Additionally, dedicated care centers within these communities provide extensive support, encompassing rest home care, hospital-level care, specialized dementia support, as well as respite and day care services. To enhance residents' lifestyles, the villages are equipped with a wide range of amenities. These include recreational facilities like all-weather bowling greens, indoor heated swimming pools with spas, gyms, croquet lawns, and movie theatres. Social and practical conveniences are also available, such as internal atriums, beauty and hairdressing salons, libraries, dining rooms, internet cafés, bars, lounges, and on-site shops. As of May 20, 2022, the company's portfolio comprised 45 operational retirement villages, accommodating approximately 8,538 independent living units and 4,239 dedicated care units. Established in 1984, Ryman Healthcare has its corporate headquarters situated in Christchurch, New Zealand.
Ryman Healthcare Limited is headquartered in NZ.
Ryman Healthcare Limited (RHCGF) stock trades at $1.08 with a market capitalization of $1.10B. The stock is valued at a price-to-earnings (P/E) ratio of -13.25, price-to-book of 0.54, price-to-sales of 2.77. Over the past 52 weeks the stock has ranged between $1.06 and $1.75, and currently trades 38.3% below its 52-week high.
On profitability, Ryman Healthcare Limited generates a return on equity (ROE) of -4.17%, return on capital employed of -0.15%, an operating margin of -2.22%, a net profit margin of -21.46%.
Official website: www.rymanhealthcare.co.nz